Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 18/20 | 0.51 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.51 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.48 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.48 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.48 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21277514 | 1.00 | P2RY2 (0.51) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL15810759 | 1.00 | P2RY2 (0.51) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL15810760 | 1.00 | P2RY2 (0.51) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL21277384 | 1.00 | P2RY2 (0.51) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL18609298 | 1.00 | P2RY2 (0.51) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL24414862 | 1.00 | P2RY2 (0.51) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL27003107 | 0.98 | B4GALT1 (0.48) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL29128824 | 0.93 | P2RY6 (0.47) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL23174033 | 0.92 | P2RY2 (0.52) | P2RY2P2RY4P2RY6B4GALT1P2RY14 | |
| SCHEMBL23172020 | 0.92 | P2RY2 (0.52) | P2RY2P2RY4P2RY6B4GALT1P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3091 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4276189-B1 | INITIATING CAPPED OLIGONUCLEOTIDE PRIMERS FOR SYNTHESIZING 5'-CAPPED RNAS | TRILINK BIOTECHNOLOGIES LLC (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4689071-A2 | MRNA THERAPEUTICS FOR OOCYTE MATURATION | Eastern Virginia Medical School (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4375367-B1 | RECOMBINANT PROTEIN OF NERVE GROWTH FACTOR MUTANT AND USE THEREOF | SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE (CN) | 2026-01-21 | — | — | EP | claimed |
| US-20250378906-A1 | METHODS AND ARRANGEMENTS FOR INTERACTIVE SIMULATION OF XRNA PRODUCTION | ARRANTA BIO HOLDINGS LLC (US) | 2025-12-11 | — | — | US | claimed |
| US-20250277180-A1 | APPARATUS, SYSTEMS AND METHODS FOR CONTINUOUS RNA MANUFACTURING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-09-04 | — | — | US | claimed |
| CN-120064427-A | Method and analysis system for detecting brain nucleic acid hydrolysate spatial distribution based on mass spectrum imaging | 北京脑科学与类脑研究所 | 2025-05-30 | — | — | CN | claimed |
| WO-2025105506-A1 | NUCLEIC ACID, DRUG COMPOSITION, AND METHOD OF PRODUCING NUCLEIC ACID | アンジェス株式会社 | 2025-05-22 | — | — | WO | claimed |
| WO-2025096982-A1 | TRANS AMPLIFYING RNAS COMPRISING CHEMICALLY MODIFIED NUCLEOBASES | AMPLITUDE THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| CN-119930721-A | NAD analogue, and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2025-05-06 | — | — | CN | claimed |
| CN-119913238-A | Compositions and methods for on-the-fly nucleic acid detection | 武汉大学 | 2025-05-02 | — | — | CN | claimed |
| WO-2015023975-A1 | COMPOSITIONS AND METHODS FOR MODULATING RNA | RANA THERAPEUTICS, INC. (US) | 2015-02-19 | — | — | WO | claimed |
| WO-2014153052-A2 | CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2014-09-25 | — | — | WO | claimed |
| US-20130195867-A1 | RNA-CODED ANTIBODY | CUREVAC GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| US-20100317005-A1 | Modified Nucleotides and Methods for Making and Use Same | Life Technologies Corporation (US) | 2010-12-16 | — | — | US | claimed |
| US-20100189729-A1 | RNA-CODED ANTIBODY | CURVAC GMBH (DE) | 2010-07-29 | — | — | US | claimed |
| US-20100047261-A1 | BASE-MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN | CUREVAC GMBH (DE) | 2010-02-25 | — | — | US | claimed |
| EP-2101823-A2 | RNA-CODED ANTIBODY | Curevac GmbH (DE) | 2009-09-23 | — | — | EP | claimed |
| EP-2083851-A2 | (BASE-)MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN | Curevac GmbH (DE) | 2009-08-05 | — | — | EP | claimed |
| WO-2008083949-A2 | RNA-CODED ANTIBODY | CUREVAC GMBH (DE) | 2008-07-17 | — | — | WO | claimed |
| WO-2008052770-A2 | (BASE-)MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN | CUREVAC GMBH (DE) | 2008-05-08 | — | — | WO | claimed |